Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Current Liabilities (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 6 years of Total Current Liabilities data on record, last reported at $44.9 million in Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 21.16% year-over-year to $44.9 million; the TTM value through Dec 2025 reached $44.9 million, down 21.16%, while the annual FY2025 figure was $44.9 million, 21.16% down from the prior year.
  • Total Current Liabilities reached $44.9 million in Q4 2025 per MRVI's latest filing, down from $69.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $165.3 million in Q1 2021 and bottomed at $44.9 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $86.7 million, with a median of $78.3 million recorded in 2023.
  • Peak YoY movement for Total Current Liabilities: surged 44.1% in 2023, then crashed 52.74% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $93.8 million in 2021, then increased by 17.45% to $110.1 million in 2022, then dropped by 20.59% to $87.5 million in 2023, then plummeted by 34.87% to $57.0 million in 2024, then decreased by 21.16% to $44.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $44.9 million in Q4 2025, $69.7 million in Q2 2025, and $63.2 million in Q1 2025.